semaglutide fda approved weight loss Ozempic® GLP for FDA approves obesity drug that

In reality: About 14% will lose less than 5% (minimal response) About 17% will lose 5-10% (modest but meaningful) About 19% will lose 10-15% (solid results) About 18% will lose 15-20% (above average) About 32% will lose 20%+ (high responders) Your individual result could fall anywhere in this distribution

One dashboard

These factors influenced the modeled risk of developing complications such as T2D, CVD, metabolic dysfunction-associated steatotic liver disease (MASLD), and OSA

Second, the combination has the potential to improve overall well-being

These considerations are even more central given the data regarding the possible application of vitamins or minerals in a therapeutic setting